ACPMP Research Foundation is pleased to announce the winners of our 2017 research grant cycle.
With these four grants, ACPMP has now issued well over ONE MILLION DOLLARS in promising research grants designed to improve the diagnosis and treatment of Appendix Cancer and Pseudomyxoma Peritonei.
The following researchers will each receive a $50,000, two-year research grant funded by ACPMP and administered by the National Organization of Rare Disorders:

J. Silvio Gutkind, PhD, University of California, San Diego (La Jolla, CA); Exploiting Systems Vulnerabilities in the Appendix Cancer and Pseudomyxoma Peritonei Oncogenome

D. Scott Merrell, PhD, Uniformed Services University of the Health Sciences (Bethesda, MD); Role of bacteria in the development and progression of pseudomyxoma peritonei

Marc Pocard, MD, PhD, Institut national de la santé et de la recherche médicale (Inserm), (Paris, France); P.A.T.R.ol 4 Cure – Pseudomyxoma Angiogenesis Translational Research Testing 4 anti-angiogenic drugs with animal models for PMP to propose a cure

Traci L. Testerman, PhD, University of South Carolina School of Medicine (Columbia, SC); Novel animal models for the study of PMP etiology and treatment

Thank you as always to our dedicated fundraisers and to the many researchers who applied.  Please stay tuned for honorary and memorial designations for each of these grants, to be announced shortly after the new year.
You can read more about our past grant recipients, including the latest updates from each of the researchers, at our Research Grants Awarded page.
ACPMP is dedicated to funding research to find a cure for Appendix Cancer and PMP.  If you would like to help us continue this important work, please consider an end of the year tax-deductible donation.